Table 4.
Polymorphisms | Alleles | Controls | ≤ 29 years | OR | 95% CI | X2 | P value | ||
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | ||||||
rs1047031 | Total | 171 | 100% | 153 | 100% | ||||
CC | 141 | 83% | 124 | 81% | Ref | ||||
CT | 28 | 16% | 29 | 19% | 1.178 | 0.664–2.088 | 0.31 | 0.57532 | |
TT | 2 | 1% | 0 | 0% | 0.227 | 0.011–4.780 | 1.75 | 0.18621 | |
CT+TT | 30 | 17% | 29 | 19% | 1.099 | 0.625–1.933 | 0.11 | 0.74261 | |
C | 310 | 91% | 277 | 91% | Ref | ||||
T | 32 | 9% | 29 | 9% | 1.014 | 0.598–1.720 | 0.00 | 0.95821 | |
rs1799946 | Total | 175 | 100% | 154 | 100% | ||||
CC | 52 | 30% | 40 | 26% | Ref | ||||
CT | 83 | 47% | 85 | 55% | 1.331 | 0.798–2.220 | 1.21 | 0.27209 | |
TT | 40 | 23% | 29 | 19% | 0.943 | 0.501–1.772 | 0.03 | 0.85410 | |
CT+TT | 123 | 70% | 114 | 74% | 1.205 | 0.742–1.956 | 0.57 | 0.45070 | |
C | 187 | 53% | 165 | 54% | Ref | ||||
T | 163 | 47% | 143 | 46% | 0.994 | 0.731–1.352 | 0.00 | 0.97076 | |
rs2738047 | Total | 176 | 100% | 155 | 100% | ||||
CC | 170 | 97% | 148 | 95% | Ref | ||||
CT | 6 | 3% | 7 | 5% | 1.340 | 0.441–4.076 | 0.27 | 0.60489 | |
TT | 0 | 0% | 0 | 0% | 1.148 | 0.023–58.221 | - | 1.00000 | |
CT+TT | 6 | 3% | 7 | 5% | 1.340 | 0.441–4.076 | 0.27 | 0.60489 | |
C | 346 | 98% | 303 | 98% | Ref | ||||
T | 6 | 2% | 7 | 2% | 1.332 | 0.443–4.007 | 0.26 | 0.60853 | |
rs11362 | Total | 171 | 100% | 155 | 100% | ||||
CC | 55 | 32% | 47 | 30% | Ref | ||||
CT | 80 | 47% | 85 | 55% | 1.243 | 0.758–2.039 | 0.75 | 0.38795 | |
TT | 36 | 21% | 23 | 15% | 0.748 | 0.389–1.435 | 0.77 | 0.38153 | |
CT+TT | 116 | 68% | 108 | 70% | 1.090 | 0.681–1.742 | 0.13 | 0.72031 | |
C | 190 | 56% | 179 | 58% | Ref | ||||
T | 152 | 44% | 131 | 42% | 0.915 | 0.671–1.248 | 0.32 | 0.57376 | |
Polymorphisms | Alleles | Controls | ˃ 29 years | OR | 95% CI | X2 | P value | ||
N | % | N | % | ||||||
rs1047031 | Total | 108 | 100% | 130 | 100% | ||||
CC | 89 | 82% | 115 | 88% | Ref | ||||
CT | 19 | 18% | 14 | 11% | 0.570 | 0.271–1.200 | 2.23 | 0.13553 | |
TT | 0 | 0% | 1 | 1% | 2.325 | 0.094–57.747 | 0.77 | 0.37991 | |
CT+TT | 19 | 18% | 15 | 12% | 0.611 | 0.294–1.270 | 1.77 | 0.18390 | |
C | 197 | 91% | 244 | 94% | Ref | ||||
T | 19 | 9% | 16 | 6% | 0.680 | 0.341–1.357 | 1.21 | 0.27147 | |
rs1799946 | Total | 107 | 100% | 131 | 100% | ||||
CC | 25 | 23% | 34 | 26% | Ref | ||||
CT | 57 | 53% | 63 | 48% | 0.813 | 0.433–1.524 | 0.42 | 0.51752 | |
TT | 25 | 24% | 34 | 26% | 1.000 | 0.482–2.076 | 0.00 | 1.00000 | |
CT+TT | 82 | 77% | 97 | 74% | 0.870 | 0.480–1.576 | 0.21 | 0.64532 | |
C | 107 | 50% | 131 | 50% | Ref | ||||
T | 107 | 50% | 131 | 50% | 1.000 | 0.697–1.435 | 0.00 | 1.00000 | |
rs2738047 | Total | 110 | 100% | 131 | 100% | ||||
CC | 105 | 95% | 126 | 96% | Ref | ||||
CT | 5 | 5% | 5 | 4% | 0.833 | 0.235–2.957 | 0.08 | 0.77754 | |
TT | 0 | 0% | 0 | 0% | 0.834 | 0.016–42.390 | - | 1.00000 | |
CT+TT | 5 | 5% | 5 | 4% | 0.833 | 0.235–2.957 | 0.08 | 0.77754 | |
C | 215 | 98% | 257 | 98% | Ref | ||||
T | 5 | 2% | 5 | 2% | 0.837 | 0.239–2.928 | 0.08 | 1.00003 | |
rs11362 | Total | 109 | 100% | 133 | 100% | ||||
CC | 37 | 34% | 52 | 39% | Ref | ||||
CT | 57 | 52% | 58 | 44% | 0.724 | 0.414–1.265 | 1.29 | 0.25608 | |
TT | 15 | 14% | 23 | 17% | 1.091 | 0.503–2.368 | 0.05 | 0.82563 | |
CT+TT | 72 | 66% | 81 | 61% | 0.800 | 0.472–1.357 | 0.68 | 0.40819 | |
C | 131 | 60% | 162 | 61% | Ref | ||||
T | 87 | 40% | 104 | 39% | 0.967 | 0.670–1.394 | 0.03 | 0.85597 |
Abbreviations: HBD-1 = human beta-defensin-1, N = number, % = percent, Ref = reference allele, OR: odds ratio